$151.182,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

The COVID-19 pandemic has had a dramatic impact on the care of patients with cardiovascular disease throughout the world. COVID-19 has a myriad of direct effects on the myocardium, vasculature, and coagulation cascade, related to the proinflammatory and prothrombotic effects of the virus, leading to an increased risk of myocardial infarction, stroke, deep venous thrombosis, and pulmonary emboli within the first 2 to 4 weeks of contracting the disease.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. The Cardiovascular Manifestations of COVID-19 - p. 153 9. Use and Prognostic Implications of Cardiac Troponin in COVID-19 - p. 163 10. Review of Immunologic Manifestations of COVID-19 Infection and Vaccination - p. 177 11. The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes - p. 185 12. A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19 - p. 197 13. Mechanical Circulatory Support in COVID-19 - p. 205 14. Extracardiac Prothrombotic Effects of COVID-19 - p. 213 15. Impact of COVID-19 on Acute Myocardial Infarction Care - p. 221 16. Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care - p. 231 17. Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease - p. 241 18. Myocarditis Following COVID-19 Vaccination - p. 251 19. Cardiovascular Health Care Implications of the COVID-19 pandemic - p. 265

Descripcion
Descripción

The COVID-19 pandemic has had a dramatic impact on the care of patients with cardiovascular disease throughout the world. COVID-19 has a myriad of direct effects on the myocardium, vasculature, and coagulation cascade, related to the proinflammatory and prothrombotic effects of the virus, leading to an increased risk of myocardial infarction, stroke, deep venous thrombosis, and pulmonary emboli within the first 2 to 4 weeks of contracting the disease.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. The Cardiovascular Manifestations of COVID-19 - p. 153 9. Use and Prognostic Implications of Cardiac Troponin in COVID-19 - p. 163 10. Review of Immunologic Manifestations of COVID-19 Infection and Vaccination - p. 177 11. The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes - p. 185 12. A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19 - p. 197 13. Mechanical Circulatory Support in COVID-19 - p. 205 14. Extracardiac Prothrombotic Effects of COVID-19 - p. 213 15. Impact of COVID-19 on Acute Myocardial Infarction Care - p. 221 16. Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care - p. 231 17. Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease - p. 241 18. Myocarditis Following COVID-19 Vaccination - p. 251 19. Cardiovascular Health Care Implications of the COVID-19 pandemic - p. 265

Indice
Autores
Muestra
Ficha Técnica